HK57097A - Bivalent metal salts of 2-N,N-di(carboxymethyl)amino 3-cyano 4-carboxymethyl 5-carboxy-thiophene-acid process for their preparation and pharmaceutical compositions containing them - Google Patents

Bivalent metal salts of 2-N,N-di(carboxymethyl)amino 3-cyano 4-carboxymethyl 5-carboxy-thiophene-acid process for their preparation and pharmaceutical compositions containing them

Info

Publication number
HK57097A
HK57097A HK57097A HK57097A HK57097A HK 57097 A HK57097 A HK 57097A HK 57097 A HK57097 A HK 57097A HK 57097 A HK57097 A HK 57097A HK 57097 A HK57097 A HK 57097A
Authority
HK
Hong Kong
Prior art keywords
carboxymethyl
cyano
amino
metal salts
thiophene
Prior art date
Application number
HK57097A
Other languages
English (en)
Inventor
Michel Wierzbicki
Jacqueline Bonnet
Martine Brisset
Yannis Tsouderos
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of HK57097A publication Critical patent/HK57097A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK57097A 1989-09-01 1997-05-01 Bivalent metal salts of 2-N,N-di(carboxymethyl)amino 3-cyano 4-carboxymethyl 5-carboxy-thiophene-acid process for their preparation and pharmaceutical compositions containing them HK57097A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8911475A FR2651497B1 (fr) 1989-09-01 1989-09-01 Nouveaux sels de metaux bivalents de l'acide n, n-di (carboxymethyl)amino-2 cyano-3 carboxymethyl-4 carboxy-5 thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant.

Publications (1)

Publication Number Publication Date
HK57097A true HK57097A (en) 1997-05-09

Family

ID=9385063

Family Applications (1)

Application Number Title Priority Date Filing Date
HK57097A HK57097A (en) 1989-09-01 1997-05-01 Bivalent metal salts of 2-N,N-di(carboxymethyl)amino 3-cyano 4-carboxymethyl 5-carboxy-thiophene-acid process for their preparation and pharmaceutical compositions containing them

Country Status (18)

Country Link
US (1) US5128367A (xx)
EP (1) EP0415850B1 (xx)
JP (1) JPH0692386B2 (xx)
AT (1) ATE100093T1 (xx)
AU (1) AU624022B2 (xx)
CA (1) CA2024419C (xx)
DE (2) DE122005000001I2 (xx)
DK (1) DK0415850T3 (xx)
ES (1) ES2062450T4 (xx)
FR (1) FR2651497B1 (xx)
HK (1) HK57097A (xx)
IE (1) IE65157B1 (xx)
LU (1) LU91125I2 (xx)
NL (1) NL300168I1 (xx)
NZ (1) NZ234770A (xx)
OA (1) OA09463A (xx)
PT (1) PT95184B (xx)
ZA (1) ZA906716B (xx)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7404967B2 (en) * 1994-12-21 2008-07-29 Cosmederm, Inc. Topical product formulations containing strontium for reducing skin irritation
FR2749759B1 (fr) * 1996-06-17 1999-11-26 Adir Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
FR2844795B1 (fr) * 2002-09-24 2004-10-22 Servier Lab Nouveau procede de synthese industriel du ranelate de strontium et de ses hydrates
FR2844796A1 (fr) * 2002-09-24 2004-03-26 Servier Lab Nouveau procede de synthese industrielle du diester methylique de l'acide 5-amino-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates
FR2844797B1 (fr) * 2002-09-24 2004-10-22 Servier Lab Nouveau procede de synthese industriel des tetraesters de l'acide 5-[bis (carboxymethyl)]-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates
FR2846558B1 (fr) * 2002-11-05 2006-07-14 Servier Lab Utilisation du sel distrontique de l'acide 2-n,n-di(carboxymethyl)amino-3-cyano-4-carboxymethyl- thiophene-5-carboxylique pour l'obtention de medicaments destines au traitement des douleurs gastro-duodenales
CA2524610C (en) * 2003-05-07 2014-03-25 Osteologix A/S Strontium combinations for prophylaxis/treatment of cartilage and/or bone conditions
PL1534305T3 (pl) 2003-05-07 2007-03-30 Osteologix As Leczenie zaburzeń chrząstek i kości solami strontu rozpuszczalnymi w wodzie
EP1622629B1 (en) * 2003-05-07 2013-07-10 Osteologix A/S Controlled-release composition containing a strontium salt
US6905723B2 (en) * 2003-05-30 2005-06-14 Depuy Products, Inc. Strontium-substituted apatite coating
US20050085531A1 (en) * 2003-10-03 2005-04-21 Hodge Carl N. Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
KR101165614B1 (ko) * 2004-02-26 2012-07-18 오스테올로지스 에이에스 괴사성 골 질환의 예방 또는 치료에 사용하기 위한스트론튬 함유 화합물
EP1744770A2 (en) 2004-05-06 2007-01-24 Osteologix A/S High yield and rapid syntheses methods for producing metallo-organic salts
US8658206B2 (en) 2004-06-25 2014-02-25 Mokwalo SA Compositions comprising strontium and vitamin D and uses thereof
FR2875807B1 (fr) * 2004-09-30 2006-11-17 Servier Lab Forme cristalline alpha du ranelate de strontium, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
CN100391955C (zh) * 2005-04-30 2008-06-04 河北医科大学 一种雷尼酸锶中间体的合成方法
US8624041B2 (en) * 2005-08-19 2014-01-07 Glenmark Generics Ltd. Process for the preparation of strontium ranelate
FR2899895B1 (fr) * 2006-04-12 2010-09-17 Servier Lab Nouveaux sels de strontium d'acides sulfoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20070292529A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating osteoporotic conditions
US20070292535A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating arthritic and or osteoporitic conditions
CN101229154B (zh) * 2007-01-26 2010-05-12 鲁南制药集团股份有限公司 治疗骨质疏松的药物组合物
FR2921367B1 (fr) * 2007-09-26 2009-10-30 Servier Lab Nouveau procede de synthese du ranelate de strontium et de ses hydrates
US20120123131A1 (en) * 2008-08-22 2012-05-17 Koilpillai Joseph Prabahar Process for the preparation of strontium ranelate
CN102227419A (zh) 2008-09-29 2011-10-26 拉蒂奥法姆有限责任公司 无水和水合形式的雷奈酸锶
CN101747316B (zh) * 2008-12-12 2013-09-25 重庆医药工业研究院有限责任公司 高纯度的雷奈酸锶及其制备方法
EP2416756A2 (en) 2009-04-10 2012-02-15 Mahmut Bilgic Stable pharmaceutical compositions with high bioavailibility
FR2953139B1 (fr) 2009-11-27 2012-04-13 Servier Lab Composition pharmaceutique comprenant un sel de strontium, de la vitamine d et une cyclodextrine
CN101775002B (zh) * 2009-12-23 2015-07-15 浙江华海药业股份有限公司 一种制备雷尼酸锶的方法
HU228820B1 (en) 2010-01-14 2013-05-28 Richter Gedeon Nyrt Process for the preparation of distrontium ranelate
IT1398542B1 (it) * 2010-03-05 2013-03-01 Chemelectiva S R L Processo per la preparazione di un polimorfo
WO2011110597A1 (de) 2010-03-11 2011-09-15 Azad Pharmaceutical Ingredients Ag Verfahren zur herstellung von strontiumranelat
WO2011124992A1 (en) 2010-03-24 2011-10-13 Actavis Group Ptc Ehf Substantially pure strontium ranelate
CN102241663B (zh) * 2010-05-10 2013-02-13 山东方明药业集团股份有限公司 一种雷奈酸锶八水合物的制备方法
WO2012046251A2 (en) * 2010-10-08 2012-04-12 Glenmark Generics Limited Novel form of ranelic acid
CN102180864B (zh) * 2011-03-28 2012-12-12 中国药科大学 一种雷尼酸锶的制备方法
CZ2011320A3 (cs) 2011-05-30 2012-12-12 Zentiva, K.S. Stabilní krystalická forma X stroncium ranelátu
EP2530068A1 (en) 2011-05-31 2012-12-05 Lacer, S.A. New strontium salts, synthesis and use thereof in the treatment of osteoporosis
WO2013013003A1 (en) 2011-07-21 2013-01-24 Emory University Methods for treating inflamatory conditions and states, and cancers by antagonizing nf-kb activation
CN102503931A (zh) * 2011-09-20 2012-06-20 浙江华海药业股份有限公司 一种雷尼酸锶晶形h的制备方法
WO2013113319A1 (en) 2012-01-31 2013-08-08 Pharmathen S.A. Process for the preparation of strontium ranelate, intermediate or hydrates thereof
EP2641905A1 (en) 2012-03-23 2013-09-25 Urquima S.A. Solid forms of strontium ranelate and processes for their preparation
US8569514B1 (en) 2012-05-17 2013-10-29 Divi's Laboratories, Ltd. Process for the preparation of strontium ranelate
CN103804345B (zh) * 2013-09-06 2017-03-15 精华制药集团股份有限公司 一种用hplc法中控制备高纯度雷尼酸锶的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3905577A1 (de) * 1989-02-23 1990-08-30 Basf Ag Diaminothiophene

Also Published As

Publication number Publication date
NL300168I2 (nl) 2005-03-01
ATE100093T1 (de) 1994-01-15
NL300168I1 (nl) 2005-03-01
EP0415850B1 (fr) 1994-01-12
CA2024419A1 (fr) 1991-03-02
JPH0692386B2 (ja) 1994-11-16
NZ234770A (en) 1991-11-26
US5128367A (en) 1992-07-07
IE65157B1 (en) 1995-10-04
AU6203390A (en) 1991-03-07
DE122005000001I2 (de) 2006-02-09
FR2651497B1 (fr) 1991-10-25
FR2651497A1 (fr) 1991-03-08
CA2024419C (fr) 1999-07-20
DE69005950D1 (de) 1994-02-24
LU91125I2 (fr) 2005-02-15
JPH03169876A (ja) 1991-07-23
PT95184B (pt) 1997-06-30
DE122005000001I1 (de) 2005-05-12
PT95184A (pt) 1991-05-22
IE903162A1 (en) 1991-03-13
ES2062450T4 (es) 2011-12-29
DK0415850T3 (da) 1994-03-21
DE69005950T2 (de) 1994-07-21
ES2062450T3 (es) 1994-12-16
ZA906716B (en) 1991-06-26
EP0415850A1 (fr) 1991-03-06
OA09463A (fr) 1992-11-15
AU624022B2 (en) 1992-05-28

Similar Documents

Publication Publication Date Title
HK57097A (en) Bivalent metal salts of 2-N,N-di(carboxymethyl)amino 3-cyano 4-carboxymethyl 5-carboxy-thiophene-acid process for their preparation and pharmaceutical compositions containing them
DK0418339T3 (da) Præparat og fremgangsmåde til forebyggelse af sammenvoksninger mellem kropsvæv
DE69021386T2 (de) Verfahren und zusammensetzungen zur heilung von geschwüren.
DE3265898D1 (en) Process for the industrial preparation of collagenous materials from human placental tissues; human collagenous materials obtained and their use in biomaterials
DK103384D0 (da) Quinoloncarboxylsyrer eller salte eller hydrater deraf, deres fremstilling og anvendelse som antibakterielle midler
DE68923819T2 (de) Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen.
IL91276A0 (en) Pharmaceutical compositions containing alpha-amino boronic acid derivatives,for the prophylaxis and treatment of virus diseases
IL94278A0 (en) 2-saccharine derivatives,their preparation and pharmaceutical compositions containing them
UA66856C2 (uk) Тієнопіримідини, спосіб їх одержання, фармацевтична композиція та спосіб її одержання
ATE84716T1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten.
ZA894945B (en) Strontium salt,process for the preparation thereof and pharmaceutical compositions containing it
ES2060440T3 (es) Derivados de acidos 1,4-dihidropiridin-dicarboxilicos aril-quinolil substituidos, procedimiento para su fabricacion y su uso en medicamentos.
ZA91762B (en) Use of benzylphosphonic acid derivatives for the treatment of diseases caused by viruses
EP0373613A3 (en) Pyridine-3-percarboxylic acid monopersulfate
CA2305764A1 (en) Bile acid salts of metals with physiological action and the use thereof in therapy
IT8448370A0 (it) Citrato trisodico utilizzabile nella cura delle malattie artriticoreumatiche
IT8520736A0 (it) Composizione medicinale e metodo per la cura delle periartriti ed affezioni similari.
NO923078D0 (no) Skumbar sammensetning for farmasoeytisk anvendelse, anvendelse derav og fremgangsmaate for behandling
ATE74767T1 (de) Arzneimittelzusammensetzung zur behandlung des lungenverstopfens.
IT8609534A0 (it) Preparato,in particolare collirio o pomata,per il trattamento di alterazioni distrofiche e vascolari dei tessuti oculari.
IT1244714B (it) Uso della benzidamina per il trattamento della placca dentaria
HU895239D0 (en) Process for the preparation of pharmaceutical compositions suitable for the treatment of skin diseases
RU94005404A (ru) Способ очистки зубных металлических протезов перед нанесением защитных покрытий

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20100830